https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/713672 Wed, 23 Oct 2024 09:00:00 -0400 https://www.bioworld.com/articles/713672-antifungal-activity-reduced-cytotoxicity-with-cot-832-in-vitro-and-in-vivo http://www.bioworld.com/articles/713645 Tue, 22 Oct 2024 09:00:00 -0400 https://www.bioworld.com/articles/713645-drug-fc-conjugate-protects-from-seasonal-and-pandemic-influenza-strains 3D illustration showing surface glycoprotein spikes hemagglutinin (purple) and neuraminidase (orange) http://www.bioworld.com/articles/713641 Tue, 22 Oct 2024 09:00:00 -0400 https://www.bioworld.com/articles/713641-first-in-class-antisense-rna-therapy-for-bk-virus-presented Doctor with illustration of kidneys http://www.bioworld.com/articles/713635 Fri, 18 Oct 2024 12:00:00 -0400 https://www.bioworld.com/articles/713635-mercks-clesrovimab-tortoise-to-beyfortus-in-rsv-race Baby with bandage on thigh Pseudomonas aeruginosa infections using D-peptide-conjugated phosphorodiamidate morpholino oligomers (D-PPMOs). P. aeruginosa is an opportunistic pathogen showing a multidrug-resistance (MDR) pattern that is at the root of significant morbidity and mortality, especially in immunocompromised patients with severe chronic lung diseases such as cystic fibrosis.]]> http://www.bioworld.com/articles/702376 Tue, 31 Oct 2023 09:00:00 -0400 https://www.bioworld.com/articles/702376-morpholino-oligomers-combat-empseudomonas-aeruginosa-em-lifestyle Biofilm growing on a petri dish http://www.bioworld.com/articles/702358 Mon, 30 Oct 2023 09:00:00 -0400 https://www.bioworld.com/articles/702358-idweek-2023-infectious-epiphenomena-in-the-climate-change-era World with digital overlay http://www.bioworld.com/articles/702115 Mon, 23 Oct 2023 09:00:00 -0400 https://www.bioworld.com/articles/702115-ligand-targeted-immunotherapy-demonstrates-excellent-antiviral-activity-in-models-of-influenza-infection Transmission electron micrograph of H1N1. H1N1 virus particles. Credit: National Institute of Allergy and Infectious Diseases, NIH http://www.bioworld.com/articles/691326 Tue, 08 Nov 2022 11:00:00 -0500 https://www.bioworld.com/articles/691326-conference-data-for-nov-8-2022-aasld http://www.bioworld.com/articles/691281 Mon, 07 Nov 2022 10:00:00 -0500 https://www.bioworld.com/articles/691281-conference-data-for-nov-7-2022-aasld http://www.bioworld.com/articles/690929 Mon, 24 Oct 2022 11:00:00 -0400 https://www.bioworld.com/articles/690929-conference-data-for-oct-24-2022-idweek http://www.bioworld.com/articles/512285 Tue, 12 Oct 2021 14:33:00 -0400 https://www.bioworld.com/articles/512285-brii-bio-shares-interim-data-on-antibody-combination-therapy-for-sars-cov-2 http://www.bioworld.com/articles/512123 Wed, 06 Oct 2021 12:00:00 -0400 https://www.bioworld.com/articles/512123-brii-bio-shares-interim-data-on-antibody-combination-therapy-for-sars-cov-2 http://www.bioworld.com/articles/511941 Thu, 30 Sep 2021 12:00:00 -0400 https://www.bioworld.com/articles/511941-roche-regeneron-cocktail-reduces-viral-load-in-hospitalized-covid-19-patients Vial and syringe http://www.bioworld.com/articles/511911 Thu, 30 Sep 2021 11:00:00 -0400 https://www.bioworld.com/articles/511911-conference-data-for-sept-30-2021-idweek http://www.bioworld.com/articles/499420 Mon, 26 Oct 2020 13:00:00 -0400 https://www.bioworld.com/articles/499420-day-zero-sees-positive-data-with-tech-to-diagnose-superbug-infections Bacteria punching antibiotic capsule http://www.bioworld.com/articles/429712 Fri, 04 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429712-despite-existential-crisis-in-antibiotic-development-hope-persists-experts-say http://www.bioworld.com/articles/429591 Thu, 03 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429591-mercks-recarbrio-shionogis-cefiderocol-tackle-bacterial-pneumonia-in-phase-iii-studies http://www.bioworld.com/articles/429592 Thu, 03 Oct 2019 00:00:00 -0400 https://www.bioworld.com/articles/429592-restorbio-burnishes-case-for-torc1-inhibitor-as-it-heads-into-phase-iii